United Health Products, Inc. (UEEC)
USD 0.27
(6.8%)
USD 0.27
(6.8%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 1.99 Million USD | -17.25% |
| 2022 | 2.41 Million USD | 106.68% |
| 2021 | 1.16 Million USD | -0.14% |
| 2020 | 1.17 Million USD | 17.36% |
| 2019 | 997.27 Thousand USD | 108.34% |
| 2018 | 478.67 Thousand USD | -55.46% |
| 2017 | 1.07 Million USD | 13.27% |
| 2016 | 948.93 Thousand USD | 11.31% |
| 2015 | 852.53 Thousand USD | -48.35% |
| 2014 | 1.65 Million USD | 36.71% |
| 2013 | 1.2 Million USD | -34.36% |
| 2012 | 1.83 Million USD | 3.65% |
| 2011 | 1.77 Million USD | 98.4% |
| 2010 | 894.51 Thousand USD | 51.06% |
| 2009 | 592.17 Thousand USD | 128.84% |
| 2008 | 258.77 Thousand USD | -16.74% |
| 2007 | 310.79 Thousand USD | 235.39% |
| 2006 | 92.66 Thousand USD | 323.52% |
| 2005 | 21.88 Thousand USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 2.12 Million USD | 4.67% |
| 2024 Q1 | 2.02 Million USD | 1.52% |
| 2023 Q3 | 2.11 Million USD | -5.27% |
| 2023 FY | 1.99 Million USD | -17.25% |
| 2023 Q2 | 2.23 Million USD | -1.92% |
| 2023 Q1 | 2.28 Million USD | -5.6% |
| 2023 Q4 | 1.99 Million USD | -5.64% |
| 2022 Q4 | 2.41 Million USD | 9.96% |
| 2022 Q2 | 2.35 Million USD | 12.46% |
| 2022 Q1 | 2.09 Million USD | 79.01% |
| 2022 FY | 2.41 Million USD | 106.68% |
| 2022 Q3 | 2.19 Million USD | -6.63% |
| 2021 Q4 | 1.16 Million USD | -2.44% |
| 2021 FY | 1.16 Million USD | -0.14% |
| 2021 Q1 | 355.31 Thousand USD | -69.64% |
| 2021 Q3 | 1.19 Million USD | 0.19% |
| 2021 Q2 | 1.19 Million USD | 236.49% |
| 2020 Q1 | 785.94 Thousand USD | -21.19% |
| 2020 Q3 | 1.41 Million USD | 40.64% |
| 2020 Q4 | 1.17 Million USD | -17.25% |
| 2020 FY | 1.17 Million USD | 17.36% |
| 2020 Q2 | 1 Million USD | 27.96% |
| 2019 Q4 | 997.27 Thousand USD | 89.6% |
| 2019 Q3 | 525.98 Thousand USD | 6.87% |
| 2019 FY | 997.27 Thousand USD | 108.34% |
| 2019 Q2 | 492.17 Thousand USD | -23.23% |
| 2019 Q1 | 641.11 Thousand USD | 33.93% |
| 2018 Q1 | 881.83 Thousand USD | -17.96% |
| 2018 Q4 | 478.67 Thousand USD | -44.15% |
| 2018 Q2 | 761.33 Thousand USD | -13.66% |
| 2018 Q3 | 857.06 Thousand USD | 12.57% |
| 2018 FY | 478.67 Thousand USD | -55.46% |
| 2017 Q4 | 1.07 Million USD | 0.38% |
| 2017 Q2 | 1.07 Million USD | 6.29% |
| 2017 FY | 1.07 Million USD | 13.27% |
| 2017 Q1 | 1.01 Million USD | 6.59% |
| 2017 Q3 | 1.07 Million USD | -0.4% |
| 2016 FY | 948.93 Thousand USD | 11.31% |
| 2016 Q3 | 1.16 Million USD | -1.56% |
| 2016 Q4 | 948.93 Thousand USD | -18.41% |
| 2016 Q1 | 858.29 Thousand USD | 0.68% |
| 2016 Q2 | 1.18 Million USD | 37.66% |
| 2015 Q3 | 1.14 Million USD | 3.6% |
| 2015 Q1 | 1.45 Million USD | -12.05% |
| 2015 Q2 | 1.1 Million USD | -24.03% |
| 2015 Q4 | 852.53 Thousand USD | -25.38% |
| 2015 FY | 852.53 Thousand USD | -48.35% |
| 2014 Q2 | 1.45 Million USD | 13.08% |
| 2014 Q4 | 1.65 Million USD | 6.79% |
| 2014 FY | 1.65 Million USD | 36.71% |
| 2014 Q1 | 1.28 Million USD | 6.57% |
| 2014 Q3 | 1.54 Million USD | 6.22% |
| 2013 Q4 | 1.2 Million USD | 10.35% |
| 2013 Q2 | 1.6 Million USD | -14.51% |
| 2013 Q3 | 1.09 Million USD | -31.62% |
| 2013 Q1 | 1.87 Million USD | 1.75% |
| 2013 FY | 1.2 Million USD | -34.36% |
| 2012 Q3 | 1.8 Million USD | 1.76% |
| 2012 FY | 1.83 Million USD | 3.65% |
| 2012 Q4 | 1.83 Million USD | 1.9% |
| 2012 Q2 | 1.77 Million USD | 1.89% |
| 2012 Q1 | 1.74 Million USD | -1.89% |
| 2011 FY | 1.77 Million USD | 98.4% |
| 2011 Q1 | 1.1 Million USD | 23.63% |
| 2011 Q3 | 1.36 Million USD | 17.35% |
| 2011 Q2 | 1.16 Million USD | 5.1% |
| 2011 Q4 | 1.77 Million USD | 30.12% |
| 2010 Q2 | 1.37 Million USD | 97.74% |
| 2010 Q3 | 950.16 Thousand USD | -31.07% |
| 2010 Q4 | 894.51 Thousand USD | -5.86% |
| 2010 FY | 894.51 Thousand USD | 51.06% |
| 2010 Q1 | 697.11 Thousand USD | 17.72% |
| 2009 FY | 592.17 Thousand USD | 128.84% |
| 2009 Q1 | 360.92 Thousand USD | 39.47% |
| 2009 Q2 | 427.11 Thousand USD | 18.34% |
| 2009 Q3 | 363.01 Thousand USD | -15.01% |
| 2009 Q4 | 592.17 Thousand USD | 63.13% |
| 2008 Q4 | 258.77 Thousand USD | -5.0% |
| 2008 Q3 | 272.41 Thousand USD | -26.49% |
| 2008 Q2 | 370.55 Thousand USD | 6.23% |
| 2008 Q1 | 348.8 Thousand USD | 12.23% |
| 2008 FY | 258.77 Thousand USD | -16.74% |
| 2007 Q1 | 200.45 Thousand USD | 116.31% |
| 2007 FY | 310.79 Thousand USD | 235.39% |
| 2007 Q4 | 310.79 Thousand USD | 14.53% |
| 2007 Q3 | 271.36 Thousand USD | 17.09% |
| 2007 Q2 | 231.76 Thousand USD | 15.62% |
| 2006 Q4 | 92.66 Thousand USD | 37.28% |
| 2006 Q3 | 67.5 Thousand USD | 0.0% |
| 2006 FY | 92.66 Thousand USD | 323.52% |
| 2005 Q4 | 21.88 Thousand USD | 0.0% |
| 2005 FY | 21.88 Thousand USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| American Medical Technologies Inc. | 2.34 Million USD | 14.936% |
| Ansell Limited | 1.32 Billion USD | 99.85% |
| Ansell Limited | 1.33 Billion USD | 99.85% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 126.33 Million USD | 98.418% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 943.17 Thousand USD | -111.93% |
| Psykey, Inc. | 2.47 Million USD | 19.206% |
| ConvaTec Group Plc | 2.01 Billion USD | 99.901% |
| ConvaTec Group Plc | 2.02 Billion USD | 99.901% |
| Encision Inc. | 1.98 Million USD | -0.751% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | 3.04 Million USD | 34.258% |
| Innovative MedTech Inc. | 6.13 Million USD | 67.418% |
| LifePoint, Inc. | 2.45 Million USD | 18.552% |
| Medite Cancer Diagnostics, Inc. | 10.18 Million USD | 80.367% |
| Paradigm Medical Industries, Inc. | 3.4 Million USD | 41.21% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | 3.04 Million USD | 34.255% |
| Reflect Scientific, Inc. | 776.32 Thousand USD | -157.477% |
| SmileDirectClub, Inc. | 982.26 Million USD | 99.797% |
| Sector 10, Inc. | 9.84 Million USD | 79.697% |
| Shandong Weigao Group Medical Polymer Company Limited | 1.35 Billion USD | 99.853% |
| SheerVision, Inc. | 1.43 Million USD | -39.644% |
| Vasamed, Inc. | 1 Million USD | -98.833% |
| Wearable Health Solutions, Inc. | 3.8 Million USD | 47.402% |
| Yubo International Biotech Limited | 2.91 Million USD | 31.403% |